• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Cart Facebook Twitter
  • About us
    • Who we are
    • What we do
    • Work for us
    • Contact us
  • News
  • Media
  • Donate

Group B Strep Support HomepageGroup B Strep Support

Working to stop GBS infection in babies

Helpline: 0330 120 0796
New to this site? START HERE →
Quick guide: What is Group B Strep?
Why and when should I test for group B Strep?
What does my test result mean?
Group B Strep infection – know the symptoms
  • Home
  • Information & Support
    • About Group B Strep
      • Group B Strep and pregnancy
      • I’ve tested positive for group B Strep
      • After your baby is born
      • Information if you’re not pregnant
      • Frequently asked questions
    • Group B Strep testing
      • When and why to order a group B Strep test
      • Different types of group B Strep tests
      • Where to order a group B Strep test
      • What does my test result mean?
    • Group B Strep infection in babies
      • Symptoms of group B Strep infection in babies
      • Treating babies for GBS infection
      • After your baby’s GBS infection
      • Group B Strep and stillbirth
      • Making a complaint or taking legal action
    • Support
      • Contact our Helpline
      • Support for Dads & Partners
      • Bereavement Support
      • Peer Support
      • Your stories and experience
  • Get Involved
    • Donate
      • Donate online
      • Giving in memory
      • Pledge your birthday
      • Leave a gift in your will
      • Corporate Support
      • Other ways to give
      • How your donation helps
    • Fundraising and events
      • Fundraising events
      • Fundraising ideas
      • Fundraise in memory
      • Fundraise at work
      • Meet the community team
      • Fundraising Resources
      • Get your school involved
      • Tell us your plans
      • Fundraising hints and tips
      • Meet our inspirational fundraisers
      • Supporter promise
    • Campaign and raise awareness
      • Share your story on our website
      • Baby Loss Awareness Week 2023
      • Group B Strep Awareness Month 2023
      • Parliamentary activity
      • Latest Petition
    • Volunteer
      • Office volunteers
      • Events volunteers
      • Fundraising volunteers
    • Shop
      • All items
      • Information Materials and Publications
      • Clothing
  • Health Professionals
    • Group B Strep in Pregnancy & Babies Conference : 15 May 2024
    • Leaflets & Posters Bulk Order form
    • UK Guidelines
    • Resources for health professionals & those in their care
    • The GBS3 Trial
    • Online training, study days and conferences
    • Changing rates of GBS infection in babies
    • Research Papers
LATEST NEWS

Health Minister announces GBS3 trial has been granted ethical approval

1st November 2019

Health Minister Nadine Dorries has announced that the GBS3 trial has been granted ethical approval.

Having made my first speech on this years ago, I’m especially thrilled to announce this.

Approval for new trial to prevent Group B Strep in newborn babies - https://t.co/CxPKLIJmsu https://t.co/ggcs6ONBR1

— Nadine Dorries (@NadineDorries) November 1, 2019

The major clinical trial is designed to improve prevention of potentially fatal group B Strep infection in newborn babies. The multi-million pound trial, which will involve 80 hospitals in England, Wales and Scotland, received the go-ahead from the Health Research Authority in England and Health & Care Research in Wales. The trial will involve at least 320,000 women, with recruitment beginning in Spring 2020.

Group B Strep is the most common cause of life-threatening infection in newborn babies, causing a range of serious infections including pneumonia, meningitis and sepsis. The results of this ground-breaking trial will be used to inform the future of pregnancy care across the United Kingdom and could help save babies’ lives every year.

The £2.8 million trial, funded by the National Institute for Health Research (NIHR), will look at the effectiveness of two different tests compared with standard care – a lab-based test, the Enriched Culture Medium (ECM) test at 35 to 37 weeks of pregnancy, and a ‘bedside test’ at the start of labour. The ECM test is currently recommended for use on high-risk groups in late pregnancy by the Royal College of Obstetricians and Gynaecologists’ clinical guidelines.

Group B Strep infections in newborn babies can usually be prevented by giving antibiotics through a vein to women during labour, which reduces the risk by up to 90%.

The UK currently does not routinely test pregnant women for group B Strep, and instead identifies pregnant women with ‘risk factors’ for their newborn developing the infection.

“We are delighted that the GBS3 trial is progressing and has the support of the Government. The results of this major trial will drive improvements in UK and international policy and lead to fewer babies and their families suffering the trauma that group B Strep infection can bring.

We are delighted that the GBS3 trial is progressing and has the support of the Government. The results of this major trial will drive improvements in UK and international policy and lead to fewer babies and their families suffering the trauma that group B Strep infection can bring.

After routine testing was introduced in the United States, the rate of early-onset group B Strep infection dropped by over 80 per cent and is now less than half that of the UK. Were the same to happen in the UK, approximately 350 babies every year would be protected from group B Strep infections, saving 15 babies’ lives and preventing another 15 from developing life-changing disability. We have to do this.”

Jane Plumb Chief Executive, Group B Strep Support

We very much look forward to the results from this pivotal GBS3 trial which may be able to improve the prevention of early-onset group B Strep infections in babies in the UK. If group B Strep carriage is diagnosed during pregnancy, compared with the current risk based approach in labour, then a significant number of babies lives could be saved.

In the meantime, we encourage all maternity units to consider testing women as recommended in the RCOG clinical guideline, including the use of the ECM test. Early-onset group B Strep infection is rare, but the complications can be serious, and further research is urgently needed to improve diagnosis.”

Mr Edward Morris MD FRCOG, Vice President of Clinical Quality at the Royal College of Obstetricians and Gynaecologists and President Elect:

At the moment, we’re in a situation where we’re missing lots of babies whose mums don’t have risk factors but do carry the bacteria and giving antibiotics to women who don’t carry the bacteria.

Dr Kate Walker, Clinical Assistant Professor of Obstetrics and GBS3 Trial Co-Lead

We want to answer the question for the NHS — should you test pregnant women for group B Strep or not, and if you’re going to test, is it better to do a culture test at 35 to 37 weeks pregnancy or a bedside test? Hopefully, the trial will answer these questions.

We believe that, if testing is proved effective, this would mean that the right women get the right antibiotics.”

Prof Jane Daniels, Professor of Clinical Trials and GBS3 Trial Co-Lead

The announcement was covered in the MailOnline:

Victory for @GBSSupport and many more - NHS to trial Group B Strep infection screening in pregnant women to protect newborns from deadly illnesess https://t.co/ydh5mDdhTW via @MailOnline

— Vanessa Chalmers (@VanessaChalmers) November 1, 2019

Share this post:

Share on X (Twitter) Share on Facebook Share on E-mail
More news
« New data on group B Strep awareness in the UK
Group B Strep Support response to Shrewsbury maternity scandal »

Footer

Group B Strep Support
PO Box 203
Haywards Heath
West Sussex
RH16 1GF

Helpline: 0330 120 0796
E: info@gbss.org.uk

Contact us

Office Hours:
Weekdays 9am to 5pm

Twitter Facebook Instagram LinkedIn Sign up for our emails
Fundraising Regulator logo
Living Wage employer logo
Community Fund logo

Group B Strep Support (GBSS) provides general information only and this should not be considered as a substitute for advice given by a health professional covering any specific situation. | GBSS © 2023 | Registered Charity 1112065 | Company 5587535 | Cookies | Privacy | Terms & Conditions

Helpline: 0330 120 0796